The Clinical Pharmacology of Cyclooxygenase-2-Selective and Dual Inhibitors

Veterinary Clinics of North America - Small Animal Practice

Volumn 36, Issue 5, 2006, Pages 1061-1085

  Clark, Terrence P ^a  

^a ELANCO ANIMAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; BUTORPHANOL; CARPROFEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DERACOXIB; DEXAMETHASONE; ENZYME INHIBITOR; ETODOLAC; FIROCOXIB; GLUCOCORTICOID; ISOENZYME; KETOPROFEN; LEVOMETHADONE; LIPOXYGENASE INHIBITOR; MELOXICAM; MEPIVACAINE; MORPHINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PETHIDINE; PLACEBO; PROSTAGLANDIN SYNTHASE; TEPOXALIN; UNCLASSIFIED DRUG; 3 (CYCLOPROPYLMETHOXY) 4 (4 METHYLSULFONYLPHENYL) 5,5 DIMETHYLFURANONE; 3-(CYCLOPROPYLMETHOXY)-4-(4-METHYLSULFONYLPHENYL)-5,5-DIMETHYLFURANONE; CARBAZOLE DERIVATIVE; DRUG DERIVATIVE; GAMMA BUTYROLACTONE; PYRAZOLE DERIVATIVE; SULFONE; THIAZINE DERIVATIVE; THIAZOLE DERIVATIVE;

CLINICAL PHARMACOLOGY; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; DRUG SELECTIVITY; DRUG TARGETING; DRUG USE; ENZYME INHIBITION; GASTROINTESTINAL TRACT; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; REVIEW; SINGLE DRUG DOSE; VETERINARY MEDICINE; ANIMAL; ANIMAL DISEASE; CAT; DOG; DRUG EFFECT; PAIN; PAIN ASSESSMENT;

ANIMALIA;

4-BUTYROLACTONE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARBAZOLES; CATS; CYCLOOXYGENASE 2 INHIBITORS; DOGS; ETODOLAC; PAIN; PAIN MEASUREMENT; PYRAZOLES; SULFONES; THIAZINES; THIAZOLES;

EID: 33748558074     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2006.07.001     Document Type: Review

References (105)

1. Goldblatt M.W. A depressor substance in seminal fluid. Journal of the Society of Chemistry 52 (1933) 1056-1057
2. van Dorp D.A., Beerthuis R.K., Nugteren D.H., et al. Enzymatic conversion of all-cis-polyunsaturated fatty acids into prostaglandins. Nature 203 (1964) 839-841
3. Bergstrom S., Danielsson H., and Samuelsson B. The enzymatic formation of prostaglandin E2 from arachidonic acid prostaglandins and related factors. Biochim Biophys Acta 90 (1964) 207-210
4. Hamberg M., Svensson J., and Samuelsson B. Prostaglandin endoperoxides. A new concept concerning the mode of action of prostaglandins. Proc Natl Acad Sci USA 71 (1974) 3824-3828
5. Hemler M., and Lands W.E. Purification of the cyclooxygenase that forms prostaglandins: demonstration of two forms of iron in the holoenzyme. J Biol Chem 251 (1976) 5575-5579
6. Miyamoto T., Ogino N., Yamamoto S., et al. Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J Biol Chem 251 (1976) 2629-2636
7. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231 (1971) 232-235
8. Flower R.J., and Vane J.R. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol 94-acetamidophenol. Nature 240 (1972) 410-411
9. Habenicht A.J., Goerig M., Grulich J., et al. Human platelet-derived growth factor stimulates prostaglandin synthesis by activation and by rapid de novo synthesis of cyclooxygenase. J Clin Invest 75 (1985) 1381-1387
10. Simmons D.L., Xie W., Chipman J.G., et al. Multiple cyclooxygenases: cloning of an inducible form. In: Baily I.M. (Ed). Prostaglandins, leukotrienes, lipoxins and PAF (1919), Plenum Press, New York 67-78
11. Kujubu D.A., Fletcher B.S., Varnum B.C., et al. TIS 10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266 (1991) 12866-12872
12. Chandrasekharan N.V., Dai H., Ross K.L., et al. COX 3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 99 (2002) 13926-13931
13. Whittle B.J.R., and Salmon J.A. In: Turnberg L.A. (Ed). Intestinal secretion (1983), Smith Kline and French Publications, Welwyn Garden City (UK) 69-73
14. Miller T.A. Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am J Physiol 245 (1983) G601-G623
15. Gerkens J.F., Gerber J.C., Shand D.G., et al. Effect of PGI2, PGE2 and 6-keto-PGF1α on canine gastric blood flow and acid secretion. Prostaglandins 16 (1978) 815-823
16. Whittle B.J., Boughton-Smith N.K., Moncada S., et al. Actions of prostacyclin (PGI2) and its product 6-oxo-PGF1α on the rat gastric mucosa in vivo and in vitro. Prostaglandins 15 (1978) 955-968
17. Allen A., and Garner A. Mucous and bicarbonate secretion in the stomach and their possible role in mucosal protection. Gut 21 (1980) 249-262
18. Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 106 Suppl (1999) 13S-24S
19. Yamagata K., Andreasson K.I., Kaufman W.E., et al. Expression of a nitrogen-inducible cyclooxygenase in brain neurons. Regulation by synaptic activity and glucocorticoids. Neuron 11 (1993) 371-378
20. Troutman M.S., Edwin S.S., Collmer D., et al. Prostaglandin H synthase-2 in human gestational tissues. Regulation in amnion. Placenta 17 (1996) 239-245
21. Chakraborty I., Das S.K., Wang J., et al. Development expression of the cyclooxygenase-1 and cyclooxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids. J Mol Endocrinol 16 (1996) 107-122
22. Krotz F., Schiele T.M., Klauss V., et al. Selective COX-2 inhibitors and risk of myocardial infarction. J Vasc Res 42 4 (2005) 312-324
23. FDA Veterinarian Newsletter. November/December 2004; XIX (VI). Available at: http://www.fda.gov/cvm/November2004.htm#5074. Accessed August 21, 2006.
24. Szezepansky A., Moatter T., Carley W.W., et al. Induction of cyclooxygenase II in human synovial microvessel endothelial cells by interleukin-I. Arthritis Rheum 198 (1994) 955-960
25. Vane J.R., and Botting R. Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med 104 Suppl (1998) 2S-8S
26. Lanenbach R., Morham S.G., Tiano H.F., et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83 (1995) 483-492
27. Morteau O., Morham S.G., Sellon R., et al. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J Clin Invest 105 (2000) 469-478
28. Reuter B.K., Asfaha S., Buret S., et al. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest 98 (1996) 2067-2085
29. Lascelles B.D., Blikslager A.T., Fox S.M., et al. Gastrointestinal tract perforation in dogs treated with a selective cyclooxygenase-2 inhibitor: 29 cases (2002-2003). J Am Vet Med Assoc 227 7 (2005) 1112-1117
30. Van Ryn J., and Pairet M. Clinical experience with cyclooxygenase-2 inhibitors. Inflamm Res 48 (1999) 247-254
31. Clark TP, Curto M, Huhn JC, et al. The effect of perioperative carprofen administration on the alleviation of pain associated with soft tissue surgery. In: Programs and Abstracts of the American College of Veterinary Anesthesia Annual Forum. New Orleans (LA): American College of Veterinary Internal Medicine, 2001.
32. Ricketts A.P., Lundy K.M., Seibel S.B., et al. Evaluation of selective inhibition of canine cyclooxygenase 1 and 2 by carprofen and other nonsteroidal anti-inflammatory drugs. Am J Vet Res 59 (1998) 1441-1446
33. Sessions J.K., et al. In vivo effects of carprofen, deracoxib and etodolac on prostanoid production in blood, gastric mucosa, and synovial fluid in dogs with chronic osteoarthritis. Am J Vet Res 66 5 (2005) 812-817
34. Straub K.M., et al. Pharmacological properties of carprofen. Eur J Rheum Inflamm 5 (1982) 478-487
35. McKellar Q.A., et al. Pharmacokinetics, tolerance and serum thromboxane inhibition of carprofen in the dog. J Small Anim Pract 31 (1990) 443-448
36. Taylor P.M., et al. Pharmacodynamic and enantioselective pharmacokinetics of carprofen in the cat. Res Vet Sci 60 (1996) 144-151
37. Vasseur P.B., et al. Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal anti-inflammatory drug, in the treatment of osteoarthritis in dogs. J Am Vet Med Assoc 206 6 (1995) 807-811
38. Fox S.M., and Campbell S. Update: two years (1997-1998) clinical experience with Rimadyl (carprofen). Pfizer Animal Health Technical Bulltin (1999), Pfizer Animal Health, New York
39. MacPhail C.M., et al. Hepatocellular toxicosis associated with administration of carprofen in 21 dogs. J Am Vet Med Assoc 212 12 (1998) 1895-1901
40. Moreau M., et al. Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis. Vet Rec 152 (2003) 323-329
41. Hanson PD, Romano D, Fleishman C, et al. Health events recorded from 575 dogs treated for osteoarthritis with firocoxib, carprofen or etodolac. In: Programs and Abstracts of the 22nd Annual Forum of the American College of Veterinary Internal Medicine Annual Forum. Minneapolis (MN), 2004.
42. Lascelles B.D., Butterworth S.J., and Waterman A.E. Postoperative analgesic and sedative effects of carprofen and pethidine in dogs. Vet Rec 134 8 (1994) 187-191
43. Welsh E.M., et al. Beneficial effects of administering carprofen before surgery in dogs. Vet Rec 141 (1997) 251-253
44. Lascelles B.D., et al. Efficacy and kinetics of carprofen, administered preoperatively or postoperatively, for the prevention of pain in dogs undergoing ovariohysterectomy. Vet Surg 27 (1998) 568-582
45. Curto M, Clark TP, Russo S, et al. Clinical pathology results in dogs administered carprofen (Rimadyl) perioperatively. Presented at the American College of Veterinary Internal Medicine, Annual Veterinary Medicine Forum. Denver, May 24, 2001.
46. Hickford F.H., Barr S.C., and Erb H.N. Effect of carprofen on hemostatic variables in dogs. Am J Vet Res 62 10 (2001) 1642-1646
47. Grisneaux E., Pibarot P., Dupuis J., et al. Comparison of ketoprofen and carprofen administered prior to orthopedic surgery for control of postoperative pain in dogs. J Am Vet Med Assoc 215 8 (1999) 1105-1110
48. Bergmann H.M., Nolte I.J., and Kramer S. Effects of preoperative administration of carprofen on renal function and hemostasis in dogs undergoing surgery for fracture repair. Am J Vet Res 66 8 (2005) 1356-1363
49. Forsyth S.F., Guilford W.G., and Pfeiffer D.U. Effect of NSAID administration on creatinine clearance in healthy dogs undergoing anaesthesia and surgery. J Small Anim Pract 41 12 (2000) 547-550
50. Lobetti R.G., et al. Effect of administration of nonsteroidal anti-inflammatory drugs before surgery on renal function in clinically normal dogs. Am J Vet Res 61 (2000) 1501-1506
51. Crandell D.E., et al. Effect of meloxicam and carprofen on renal function when administered to healthy dogs prior to anesthesia and painful stimulation. Am J Vet Res 65 (2004) 1384-1390
52. Alibhai H.I.K., and Clarke K.W. Influence of carprofen on minimum alveolar concentration of halothane in dogs. J Vet Pharmacol Ther 19 (1996) 320-321
53. Lascelles B.D., Cripps P., Mirchandani S., et al. Carprofen as an analgesic for postoperative pain in cats: dose titration and assessment of efficacy in comparison to pethidine hydrochloride. J Small Anim Pract 36 12 (1995) 535-541
54. Balmer T.V., Irvine D., Jones R.S., et al. Comparison of carprofen and pethidine as postoperative analgesics in the cat. J Small Anim Pract 39 4 (1998) 158-164
55. Al-Gizawiy M.M., and Rude P.E. Comparison of preoperative carprofen and postoperative butorphanol as postsurgical analgesics in cats undergoing ovariohysterectomy. Vet Anaesth Analg 31 3 (2004) 164-174
56. Slingsby L.S., and Waterman-Pearson A.E. Postoperative analgesia in the cat after ovariohysterectomy by use of carprofen, ketoprofen, meloxicam or tolfenamic acid. J Small Anim Pract 41 10 (2000) 447-450
57. Mollenhoff A., Nolte I., and Kramer S. Anti-nociceptive efficacy of carprofen, levomethadone and buprenorphine for pain relief in cats following major orthopaedic surgery. J Vet Med A Physiol Pathol Clin Med 52 4 (2005) 186-198
58. Parton K., Balmer T.V., Boyle J., et al. The pharmacokinetics and effects of intravenously administered carprofen and salicylate on gastrointestinal mucosa and selected biochemical measurements in healthy cats. J Vet Pharmacol Ther 23 2 (2000) 73-79
59. Clark T.P., Chieffo C., Huhn J.C., et al. The steady-state pharmacokinetics and bioequivalence of carprofen administered orally and subcutaneously in dogs. J Vet Pharmacol Ther 26 3 (2003) 187-192
60. Runk A., Kyles A.E., and Downs M.O. Duodenal perforation in a cat following the administration of nonsteroidal anti-inflammatory medication. J Am Anim Hosp Assoc 35 1 (1999) 52-55
61. Wilson J.E., Chandrasekharan N.V., Westover K.D., et al. Determination of expression of cyclooxygenase-1 and -2 isozymes in canine tissues and their differential sensitivity to nonsteroidal anti-inflammatory drugs. Am J Vet Res 65 6 (2004) 810-818
62. Reimer M.E., et al. The gastroduodenal effects of buffered aspirin, carprofen, and etodolac in healthy dogs. J Vet Intern Med 13 (1999) 472-477
63. Nishihara K., Kikuchi H., Kanno T., et al. Comparison of the upper gastrointestinal effects of etodolac and aspirin in healthy dogs. J Vet Med Sci 63 10 (2001) 1131-1133
64. Streppa H.K., Jones C.J., and Budsberg S.C. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs in canine blood. Am J Vet Res 63 1 (2002) 91-94
65. Budsberg S.C., Johnston S.A., Schwarz P.D., et al. Efficacy of etodolac for the treatment of osteoarthritis of the hip joints in dogs. J Am Vet Med Assoc 214 2 (1999) 206-210
66. Ness T.A., Torres S.M., Kramek E.A., et al. Effect of dosing and sampling time on serum thyroxine, free thyroxine, and thyrotropin concentrations in dogs following multidose etodolac administration. Vet Ther 4 4 (2003) 340-349
67. Panciera D.L., and Johnston S.A. Results of thyroid function tests and concentrations of plasma proteins in dogs administered etodolac. Am J Vet Res 63 11 (2002) 1492-1495
68. Hampshire V.A., Doddy F.M., Post L.O., et al. Adverse drug event reports at the United States Food and Drug Administration Center for Veterinary Medicine. J Am Vet Med Assoc 225 4 (2004) 533-536
69. Stiles J. Warning of an adverse effect of etodolac. J Am Vet Med Assoc 225 4 (2004) 503
70. Inoue T., Ko J.C., Mandsager R.E., et al. Efficacy and safety of preoperative etodolac and buttorphanol administration in dogs undergoing ovariohysterectomy. J Am Anim Hosp Assoc 42 3 (2006) 178-188
71. Kay-Mugford P., et al. In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenase activity in dogs. Am J Vet Res 61 (2000) 802-810
72. Brideau C., et al. In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs and cats. Am J Vet Res 62 (2001) 1755-1760
73. Boston S.E., et al. Endoscopic evaluation of the gastroduodenal mucosa to determine the safety of short-term concurrent administration of meloxicam and dexamethasone in healthy dogs. Am J Vet Res 63 (2003) 1369-1375
74. Forsyth S.F., et al. Endoscopy of the gastroduodenal mucosa after carprofen, meloxicam and ketoprofen administration in dogs. J Small Anim Pract 39 (1998) 421-424
75. Jones C.J., et al. In vivo effects of meloxicam and aspirin on blood, gastric mucosal, and synovial fluid prostanoid synthesis in dogs. Am J Vet Res 63 (2002) 1527-1531
76. Cross A.R., Budsberg S.C., and Keefe T.J. Kinetic gait analysis assessment of meloxicam efficacy in a sodium urate-induced synovitis model in dogs. Am J Vet Res 58 6 (1997) 626-631
77. Borer L.R., Peel J.E., Seewald W., et al. Effect of carprofen, etodolac, meloxicam, or butorphanol in dogs with induced acute synovitis. Am J Vet Res 64 11 (2003) 1429-1437
78. Doig P.A., et al. Clinical efficacy and tolerance of meloxicam in dogs with chronic arthritis. Can Vet J 41 (2000) 296-300
79. Nell T., Bergman J., Hoeijmakers M., et al. Comparison of vedaprofen and meloxicam in dogs with musculoskeletal pain and inflammation. J Small Anim Pract 43 5 (2002) 208-212
80. Peterson K.D., and Keefe T.J. Effects of meloxicam on severity of lameness and other clinical signs of osteoarthritis in dogs. J Am Vet Med Assoc 225 7 (2004) 1056-1060
81. Nakagawa K., Yamagami T., and Takemura N. Hepatocellular toxicosis associated with the alternate administration of carprofen and meloxicam in a Siberian husky. J Vet Med Sci 67 10 (2005) 1051-1053
82. Duerr F.M., Carr A.P., Bebchuk T.N., et al. Challenging diagnosis-icterus associated with a single perforating duodenal ulcer after long-term nonsteroidal antiinflammatory drug administration in a dog. Can Vet J 45 6 (2004) 507-510
83. Reed S. Nonsteroidal anti-inflammatory drug-induced duodenal ulceration and perforation in a mature rottweiler. Can Vet J 43 12 (2002) 971-972
84. Caulkett N., Read M., Fowler D., et al. A comparison of the analgesic effects of butorphanol with those of meloxicam after elective ovariohysterectomy in dogs. Can Vet J 44 7 (2003) 565-570
85. Mathews K.A., Pettifer G., Foster R., et al. Safety and efficacy of preoperative administration of meloxicam, compared with that of ketoprofen and butorphanol in dogs undergoing abdominal surgery. Am J Vet Res 62 6 (2001) 882-888
86. Leece E.A., Brearley J.C., and Harding E.F. Comparison of carprofen and meloxicam for 72 hours following ovariohysterectomy in dogs. Vet Anaesth Analg 32 4 (2005) 184-192
87. Fresno L., Moll J., Penalba B., et al. Effects of preoperative administration of meloxicam on whole blood platelet aggregation, buccal mucosal bleeding time, and haematological indices in dogs undergoing elective ovariohysterectomy. Vet J 170 1 (2005) 138-140
88. Deneuche A.J., Dufayet C., Goby L., et al. Analgesic comparison of meloxicam or ketoprofen for orthopedic surgery in dogs. Vet Surg 33 6 (2004) 650-660
89. Laredo F.G., Belda E., Murciano J., et al. Comparison of the analgesic effects of meloxicam and carprofen administered preoperatively to dogs undergoing orthopaedic surgery. Vet Rec 155 21 (2004) 667-671
90. Fowler D., Isakow K., Caulkett N., et al. An evaluation of the analgesic effects of meloxicam in addition to epidural morphine/mepivacaine in dogs undergoing cranial cruciate ligament repair. Can Vet J 44 8 (2003) 643-648
91. Budsberg S.C., Cross A.R., Quandt J.E., et al. Evaluation of intravenous administration of meloxicam for perioperative pain management following stifle joint surgery in dogs. Am J Vet Res 63 11 (2002) 1557-1563
92. Giraudel J.M., Toutain P.L., and Lees P. Development of in vitro assays for the evaluation of cyclooxygenase inhibitors and predicting selectivity of nonsteroidal anti-inflammatory drugs in cats. Am J Vet Res 66 4 (2005) 700-709
93. Lascelles B.D., Henderson A.J., and Hackett I.J. Evaluation of the clinical efficacy of meloxicam in cats with painful locomotor disorders. J Small Anim Pract 42 12 (2001) 587-593
94. Carroll G.L., Howe L.B., and Peterson K.D. Analgesic efficacy of preoperative administration of meloxicam or butorphanol in onychectomized cats. J Am Vet Med Assoc 226 6 (2005) 913-919
95. Slingsby L.S., and Waterman-Pearson A.E. Comparison between meloxicam and carprofen for postoperative analgesia after feline ovariohysterectomy. J Small Anim Pract 43 7 (2002) 286-289
96. Gassel A.D., Tobias K.M., Egger C.M., et al. Comparison of oral and subcutaneous administration of buprenorphine and meloxicam for preemptive analgesia in cats undergoing ovariohysterectomy. J Am Vet Med Assoc 227 12 (2005) 1937-1944
97. Sennello KA, Leib MS. Comparison of the effects of deracoxib, buffered aspirin, and placebo on the gastric mucosa of healthy dogs. In: Programs and Abstracts of the American College of Veterinary Internal Medicine Annual Forum. 2004.
98. Millis D.L., Weigel J.P., Moyers T., et al. Effect of deracoxib, a new COX-2 inhibitor, on the prevention of lameness induced by chemical synovitis in dogs. Vet Ther 3 4 (2002) 453-464
99. Gassel A.D., Tobias K.M., and Cox S.K. Disposition of deracoxib in cats after oral administration. J Am Anim Hosp Assoc 42 3 (2006) 212-217
100. McCann M.E., Andersen D.R., Zhang D., et al. In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in dogs with experimentally induced synovitis. Am J Vet Res 65 4 (2004) 503-512
101. Lever D, Gogolewski R, Larsen D, et al. Management of peri-operative pain associated with soft tissue surgery in dogs treated with firocoxib. In: Programs and Abstracts of the American College of Veterinary Internal Medicine Annual Forum. 2004.
102. McCann M.E., Rickes E.L., Hora D.F., et al. In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide induced pyrexia. Am J Vet Res 66 7 (2005) 1278-1284
103. Argentieri D.C., Ritchie D.M., Ferro M.P., et al. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile. J Pharmacol Exp Ther 271 3 (1994) 1399-1408
104. Agnello K.A., Reynolds L.R., and Budsberg S.C. In vivo effects of tepoxalin, an inhibitor of cyclooxygenase and lipoxygenase, on prostanoid and leukotriene production in dogs with chronic osteoarthritis. Am J Vet Res 66 6 (2005) 966-972
105. Kay-Mugford P.A., Grimm K.A., Weingarten A.J., et al. Effect of preoperative administration of tepoxalin on hemostasis and hepatic and renal function in dogs. Vet Ther 5 2 (2004) 120-127